Multidrug-resistant mutations to antiviral and antibody therapy in an immunocompromised patient infected with SARS-CoV-2-Reference-Cited by-同舟云学术

Multidrug-resistant mutations to antiviral and antibody therapy in an immunocompromised patient infected with SARS-CoV-2

Published:2023-11 Issue:11 Volume:4 Page:813-824.e4
ISSN:2666-6340
Container-title:Med
language:en
Short-container-title:Med

Author:

Hirotsu Yosuke^ORCID,Kobayashi Hiroaki,Kakizaki Yumiko,Saito Akitoshi,Tsutsui Toshiharu,Kawaguchi Makoto,Shimamura Sou,Hata Kouki,Hanawa Syunya,Toyama Jun,Miyashita Yoshihiro,Omata Masao

Publisher

Elsevier BV

Subject

General Medicine

Reference59 articles.

1. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine;Polack;N. Engl. J. Med.,2020

2. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine;Baden;N. Engl. J. Med. Overseas. Ed.,2021

3. Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab;Gupta;N. Engl. J. Med.,2021

4. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19;Sadoff;N. Engl. J. Med.,2021

5. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19;Weinreich;N. Engl. J. Med.,2021

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The significance of recurrent de novo amino acid substitutions that emerged during chronic SARS-CoV-2 infection: an observational study;eBioMedicine;2024-09

2. Drug susceptibility and the potential for drug-resistant SARS-CoV-2 emergence in immunocompromised animals;iScience;2024-09

3. Generative artificial intelligence performs rudimentary structural biology modeling;Scientific Reports;2024-08-21

4. The small molecule inhibitor of SARS-CoV-2 3CLpro EDP-235 prevents viral replication and transmission in vivo;Nature Communications;2024-08-01

5. In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillance;Science Advances;2024-07-26